These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3538552)

  • 1. Enumeration of transferrin-receptor-expressing lymphocytes as a potential marker for rejection in human cardiac transplant recipients.
    Mohanakumar T; Hoshinaga K; Wood NL; Szentpetery S; Lower RR
    Transplantation; 1986 Dec; 42(6):691-4. PubMed ID: 3538552
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of transferrin receptors on lymphocytes: its correlation with T-helper/T-suppressor cytotoxic ratio and rejection in heart transplant recipients.
    Hoshinaga K; Mohanakumar T; Pascoe EA; Szentpetery S; Lee HM; Lower RR
    J Heart Transplant; 1988; 7(3):198-204. PubMed ID: 2968444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in transferrin receptors as a marker for rejection and infection in human cardiac transplantation.
    Hoshinaga K; Mohanakumar T; Wood NL; Szentpetery S; Lower RR
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2534-6. PubMed ID: 3274556
    [No Abstract]   [Full Text] [Related]  

  • 4. Transferrin receptors and CD4/CD8 lymphocyte ratios in rejection and infection in cardiac transplantation recipients.
    Mooney ML; Carlson P; Hastillo A; Szentpetery S; Duma RJ; Markowitz SM
    Transplant Proc; 1990 Oct; 22(5):2389-93. PubMed ID: 2120819
    [No Abstract]   [Full Text] [Related]  

  • 5. [Analyses of the transferrin and IL-2 receptors expression on lymphocytes from kidney transplant recipients at the onset of acute rejection: preliminary report].
    Yoshimura N; Oka T; Ohmori Y; Aikawa I
    Nihon Geka Gakkai Zasshi; 1989 May; 90(5):794. PubMed ID: 2796950
    [No Abstract]   [Full Text] [Related]  

  • 6. Relevance of immunological parameters to detect allograft rejection in heart transplant recipients.
    Renna Molajoni E; Bachetoni A; Cinti P; Sallusto F; Alfani D; Macchiarelli A; Scibilia G; Cassisi A; Marino B; Cortesini R
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2534-6. PubMed ID: 2650326
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression of early and late activation markers on peripheral blood T lymphocytes does not reliably reflect immune events in transplanted hearts.
    Loertscher R; Forbes RD; Halabi G; Lavery P; Quinn T
    Clin Transplant; 1994 Jun; 8(3 Pt 1):230-8. PubMed ID: 8061361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of the clinical utility of lymphocyte monitoring in the cardiac transplant recipient.
    Mooney ML; Carlson P; Szentpetery S; Duma RJ; Markowitz SM
    Transplantation; 1990 Dec; 50(6):951-4. PubMed ID: 2124008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lymphocyte subpopulations in cyclosporine-treated human heart rejection.
    Weintraub D; Masek M; Billingham ME
    J Heart Transplant; 1985 Feb; 4(2):213-6. PubMed ID: 3916488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological diagnosis of rejection in heart transplant recipients.
    Molajoni ER; Cinti P; Bachetoni A; Sallusto F; Caricato M; Mancini C; Mazzesi G; Marino B; Alfani D; Cortesini R
    Bibl Cardiol; 1988; (43):142-5. PubMed ID: 3067714
    [No Abstract]   [Full Text] [Related]  

  • 11. [Identification of a cardiac allograft rejection marker using microarray gene expression analysis in lymphocytes from heart transplant patients].
    Hermida-Prieto M; Crespo-Leiro MG; Paniagua MJ; Castro-Beiras A
    Rev Esp Cardiol; 2007 Feb; 60(2):217-8. PubMed ID: 17338892
    [No Abstract]   [Full Text] [Related]  

  • 12. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.
    Hüser N; Tertilt C; Gerauer K; Maier S; Traeger T; Assfalg V; Reiter R; Heidecke CD; Pfeffer K
    Eur J Immunol; 2005 Jan; 35(1):128-38. PubMed ID: 15593118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease.
    Lietz K; John R; Burke E; Schuster M; Rogers TB; Suciu-Foca N; Mancini D; Itescu S
    Circulation; 2005 Oct; 112(16):2468-76. PubMed ID: 16230499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil transendothelial migration potential predicts rejection severity in human cardiac transplantation.
    Healy DG; Watson RW; O'Keane C; Egan JJ; McCarthy JF; Hurley J; Fitzpatrick J; Wood AE
    Eur J Cardiothorac Surg; 2006 May; 29(5):760-6. PubMed ID: 16616855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-organ transplantation: is there a protective effect against acute and chronic rejection?
    Pinderski LJ; Kirklin JK; McGiffin D; Brown R; Naftel DC; Young KR; Smith K; Bourge RC; Tallaj JA; Rayburn BK; Benza R; Zorn G; Leon K; Wille K; Deierhoi M; George JF
    J Heart Lung Transplant; 2005 Nov; 24(11):1828-33. PubMed ID: 16297789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-TNF-alpha treatment down-regulates the expression of fibronectin and decreases cellular infiltration of cardiac allografts in rats.
    Coito AJ; Binder J; Brown LF; de Sousa M; Van de Water L; Kupiec-Weglinski JW
    J Immunol; 1995 Mar; 154(6):2949-58. PubMed ID: 7876561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacy.
    Lietz K; John R; Beniaminovitz A; Burke EM; Suciu-Foca N; Mancini DM; Edwards NM; Itescu S
    Transplantation; 2003 Mar; 75(6):781-7. PubMed ID: 12660501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of in vitro propagation of activated lymphocytes from endomyocardial biopsy samples of pediatric heart transplant recipients.
    Webber SA; Bentlejewski C; Park A; Fricker FJ; Griffith C; Boyle GJ; Miller SA; Pham S; Murali S; Griffith BP; Duquesnoy R; Zeevi A
    Pediatr Transplant; 1998 Aug; 2(3):200-5. PubMed ID: 10084743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac troponin T: a noninvasive marker for heart transplant rejection?
    Alexis JD; Lao CD; Selter JG; Courtney MC; Correa DK; Lansman SL; Kushwaha SS; Gass AL
    J Heart Lung Transplant; 1998 Apr; 17(4):395-8. PubMed ID: 9588584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease.
    Kerman RH; Susskind B; Kerman D; Lam M; Gerolami K; Williams J; Kalish R; Campbell M; Katz S; Van Buren CT; Frazier H; Radovancevic B; Fife S; Kahan B
    J Heart Lung Transplant; 1998 Aug; 17(8):789-94. PubMed ID: 9730428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.